Introduction Macaques play a central role in human tuberculosis(TB) vaccine development. Immune and challenge responses differ across macaque and human subpopulations. We determined which macaque subpopulations best predicted immune responses in different human subpopulations, using novel immunostimulation/immunodynamic modelling methods in a proof of concept study. Methods Data on IFN-γ secreting CD4+ T cells over time after recent BCG vaccination were available for 55 humans and 81 macaques. Human population covariates were: baseline BCG vaccination status, time since BCG vaccination, gender and monocyte/lymphocyte cell count ratio. The macaque population covariate was colony of origin. A two-compartment mathematical ...
The lack of validated immunological correlates of protection makes tuberculosis vaccine development ...
Correlates of immune protection that reliably predict vaccine efficacy against Mycobacterium tubercu...
Tuberculosis (TB) is the leading cause of death by an infectious agent, and developing an effective ...
Introduction: Macaques play a central role in human tuberculosis(TB) vaccine development. Immune and...
Macaques play a central role in the development of human tuberculosis (TB) vaccines. Immune and chal...
Introduction: In 2010, 1.4 million people died from tuberculosis. Bacille Calmette Guerin (BCG) is t...
In many countries where tuberculosis (TB) is endemic, the Bacillus Calmette–Guérin (BCG) vaccine is ...
Tuberculosis (TB) is the leading cause of death by an infectious agent, and developing an effective ...
To this day, tuberculosis remains a complex global health problem, the elimination of which is hinde...
This study describes the use of cynomolgus macaques of Chinese origin (CCM) to evaluate the efficacy...
Bacille Calmette-Guérin (BCG) motivate the search for better vaccine regimes. Relevant models are r...
AbstractIntradermal (ID) BCG injection provides incomplete protection against TB in humans and exper...
In countries where tuberculosis (TB) is endemic, BCG is recommended close after birth to protect inf...
Tuberculosis (TB) is one of the greatest global health challenges society faces. BCG, the only licen...
Background: Preclinical animal experiments measuring vaccine immunogenicity and safety are essential...
The lack of validated immunological correlates of protection makes tuberculosis vaccine development ...
Correlates of immune protection that reliably predict vaccine efficacy against Mycobacterium tubercu...
Tuberculosis (TB) is the leading cause of death by an infectious agent, and developing an effective ...
Introduction: Macaques play a central role in human tuberculosis(TB) vaccine development. Immune and...
Macaques play a central role in the development of human tuberculosis (TB) vaccines. Immune and chal...
Introduction: In 2010, 1.4 million people died from tuberculosis. Bacille Calmette Guerin (BCG) is t...
In many countries where tuberculosis (TB) is endemic, the Bacillus Calmette–Guérin (BCG) vaccine is ...
Tuberculosis (TB) is the leading cause of death by an infectious agent, and developing an effective ...
To this day, tuberculosis remains a complex global health problem, the elimination of which is hinde...
This study describes the use of cynomolgus macaques of Chinese origin (CCM) to evaluate the efficacy...
Bacille Calmette-Guérin (BCG) motivate the search for better vaccine regimes. Relevant models are r...
AbstractIntradermal (ID) BCG injection provides incomplete protection against TB in humans and exper...
In countries where tuberculosis (TB) is endemic, BCG is recommended close after birth to protect inf...
Tuberculosis (TB) is one of the greatest global health challenges society faces. BCG, the only licen...
Background: Preclinical animal experiments measuring vaccine immunogenicity and safety are essential...
The lack of validated immunological correlates of protection makes tuberculosis vaccine development ...
Correlates of immune protection that reliably predict vaccine efficacy against Mycobacterium tubercu...
Tuberculosis (TB) is the leading cause of death by an infectious agent, and developing an effective ...